Data-driven platform selection for automated cell therapy manufacturing (APAC)

Tuesday 10:00 IST / 12:30 AWST / 13:30 KST / 13:30 JST / 14:30 AEST / 16:30 NZST

Sponsor

Data-driven platform selection for automated cell therapy manufacturing (APAC)

Choosing the right automated manufacturing platform can make or break a cell therapy program – yet developers often lack transparent, objective data to guide that decision. This webinar offers a structured, evidence-based comparison as well as evaluation criteria to help fill that gap.

Join a process development expert from Charles River and a field application specialist from Cytiva as they walk through a real-world, head-to-head evaluation of the Sefia™ platform and a leading all-in-one automated manufacturing system. You’ll see biological performance data generated from three parallel runs using identical media and reagents, providing a rare, evidence-based assessment of process outcomes and operational considerations.

This session will also break down practical criteria to apply when assessing automation technologies, from workflow compatibility to performance, and share lessons learned from the transition to automated manufacturing systems.

Key takeaways:

Review side-by-side biological data comparing the Sefia™ platform and a leading all-in-one automated manufacturing system across three equivalent process runs
Understand practical criteria for evaluating automated cell therapy manufacturing platforms, including workflow compatibility, operational flexibility, and scalability
Learn how CDMOs assess automation technologies using both biological performance data and operational considerations
Gain a decision-making framework you can apply to your own platform selection and long-term manufacturing strategy

Register to gain real-world data and practical CDMO insights for informed selection of automated cell therapy manufacturing platforms.

Alex Sargent, PhD

Director of Process Development at Charles River Laboratories

Alex Sargent – better known as “Sarge” – is the Director of Process Development at Charles River Laboratories. He obtained his PhD from Case Western Reserve University in Cleveland, Ohio, where he studied the challenges and promises of stem cell biology, neuroimmunology, and Cleveland sports teams. After a brief stint in academia at the Cleveland Clinic, he left Cleveland to pursue his industry career in cell therapy. During his many years in this industry, he has had the honor of working at several esteemed enterprises on new technologies and approaches for cell therapy scale up, automation, and gene editing. He is especially passionate about the challenge of curing cancer, working on CAR-T and CAR-NK cell therapy process and analytical development from discovery through regulatory submission, manufacturing, and pivotal clinical trials. He wakes up each day excited to help advance cell and gene therapy to treat and cure disease, with the steadfast goal of improving human lives.

Eu Han Lee, PhD

Senior Field Application Specialist at Cytiva

Eu Han Lee is a dedicated scientist with a strong and extensive scientific background, currently serving as a Senior Field Application Specialist in customer support. He partners closely with customers to deliver tailored solutions for research and clinical challenges, with a particular focus on cell therapy manufacturing. Drawing on deep technical expertise and hands-on experience, Eu Han provides high-value scientific support that helps advance robust, scalable cell therapy processes.

In 32 Days

You have registered for this webinar